Table 1.
Neoplasm type | GNAQ mutations | Citation |
---|---|---|
Uveal melanoma | 46-49% | Onken et al, Van Raamsdonk et al |
Mucosal melanoma | 0% | Van Raamsdonk et al, Present study |
Cutaneous melanoma (acral sites) | 0% | Van Raamsdonk et al, Present study |
Cutaneous melanoma (non-acral sites with chronic sun-induced damage) | 0-4% | Van Raamsdonk et al, Present study |
Blue nevus | 46-83% | Lamba et al, Van Raamsdonk et al |
Malignant blue nevus | 50% | Van Raamsdonk et al |
Nevus of Ota | 6-46% | Lamba et al, Van Raamsdonk et al |
Congenital nevus | 0% | Van Raamsdonk et al |
Deep penetrating nevus | 0% | Van Raamsdonk et al |
Spitz nevus | 0% | Van Raamsdonk et al |
Primary melanocytic neoplasms of the central nervous system | 37% | Kusters-Vandevelde et al |
Other neoplasms (carcinoma of the breast, colon, bladder, lung, ovarian, pancreas, thyroid; gastrointestinal stromal tumor; glioma; acute myelogenous leukemia) | 0% | Lamba et al |
ND, not determined